Viewing Study NCT00285402


Ignite Creation Date: 2025-12-25 @ 3:46 AM
Ignite Modification Date: 2026-02-21 @ 11:35 PM
Study NCT ID: NCT00285402
Status: UNKNOWN
Last Update Posted: 2008-02-08
First Post: 2006-01-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine
Sponsor: Ariston Pharmaceuticals, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ARPH-Cl-03
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: John A. McLane
Old Organization: Ariston Pharmaceuticals, Inc

Collaborators